If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOndo Insurtech Regulatory News (ONDO)

Share Price Information for Ondo Insurtech (ONDO)

Share Price is delayed by 15 minutes
Get Live Data
6.70    0.52 (8.41%)
Bid:
6.40
Ask:
7.00
Spread: 0.60 (9.375%)
Market Cap: £10.04m
ONDO Live PriceLast checked at - London Stock Exchange

Intraday Ondo Insurtech Share Chart

Director share dealing

5 Sep 2024 07:00

RNS Number : 9571C
Ondo InsurTech PLC
05 September 2024
 

5 September 2024

Ondo Insurtech Plc

("Ondo" or "the Company")

 

Director share dealing

 

Ondo Insurtech (LSE: ONDO), a leading company in claims prevention technology for home insurers, announces that Kevin Withington, the Company CFO, has transferred 137,931 Ondo ordinary shares of 5p each ("Ordinary Shares") from his personal holding into his Personal Individual Savings Account ("ISA") a Bed and ISA transaction.

 

Following this transaction Mr Withington remains interested in 290,238 Ordinary Shares representing 0.25 per cent of the Company's issued share capital.

 

 

Enquiries

 

Ondo InsurTech Plc

Craig Foster, CEO

Kevin Withington, CFO

+44 (0) 800 783 9866

Dowgate Capital Ltd

(Broker & Financial Advisor)

Russell Cook

Nick Chambers

Charlie Hall

+44 (0) 20 3903 7715

 

Cassiopeia Services Ltd

(PR & Investor Relations)

Stefania Barbaglio

 +44 (0) 7949 690338

 

 

 

The information set out below is provided in accordance with the requirements of Article 19 of the Market Abuse Regulations.

 

1.

Details of PDMR / person closely associated with them ("PCA").

a)

Name

Kevin Withington

2

Reason for notification

a)

Position/Status

Chief Financial Officer

b)

Initial Notification / amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer

or auction monitor

a)

Name

Ondo InsurTech Plc

b)

LEI

2138005Y5QBJQMOOI719

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial

Ordinary shares of 5 pence each

instrument, type of instrument

and identification code

ISIN: GB00BNVVGD77

b)

Nature of transaction

Bed and ISA (involving both a sale and purchase of Ordinary Shares)

c)

Price(s) and volume(s)

 

Sale 14.5p 137,931

 

Purchase 14.5p 137,931

 

d)

Aggregated information

n/a

e)

Date of transaction

3 September 2024

f)

Place of transaction

London Stock Exchange, Main Market (XLON)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUSSNRSVUKRAR
Date   Source Headline
30th Sep 20257:00 amRNSTotal Voting Rights
22nd Sep 20254:08 pmRNSResult of AGM
22nd Sep 20257:00 amRNSAGM Statement
4th Sep 20253:30 pmRNSDirector/PDMR Shareholding
3rd Sep 20257:00 amRNSContract
26th Aug 20257:00 amRNS-RTopdanmark agreement update
15th Aug 20253:00 pmRNSNotice of AGM
4th Aug 20254:47 pmRNSHolding(s) in Company
4th Aug 20253:10 pmRNSHolding(s) in Company
4th Aug 20257:00 amRNSDirectorate Change
1st Aug 20251:32 pmRNSDirector/PDMR Shareholding
1st Aug 20259:03 amRNSBlock listing Interim Review
1st Aug 20258:56 amRNSTotal Voting Rights
30th Jul 20257:30 amRNSWarrant Exercise
30th Jul 20257:00 amRNSAnnual Financial Report
28th Jul 20251:44 pmRNSHolding(s) in Company
24th Jul 20257:00 amRNS-RLeakBot Partnership with vipHomeLink in the U.S.
7th Jul 20251:00 pmRNSNotice of Results
1st Jul 20257:00 amRNSDirector/PDMR Shareholding
30th Jun 20257:30 amRNSTotal Voting Rights
30th Jun 20257:05 amRNSDirector/PDMR Shareholding
26th Jun 202512:30 pmRNSDirector/PDMR Shareholding
19th Jun 20254:01 pmRNSDirector/PDMR Shareholding
16th Jun 20257:00 amRNSBear River Mutual to Pilot LeakBot in the US
12th Jun 20257:00 amRNSDirector/PDMR Shareholding
30th May 202510:01 amRNSDirector/PDMR Shareholding
6th May 202512:34 pmRNSHolding(s) in Company
1st May 202510:00 amRNSDirector/PDMR Shareholding
1st May 202510:00 amRNSTotal Voting Rights
15th Apr 20255:06 pmRNSDirector/PDMR Shareholding
11th Apr 20257:00 amRNSThe Hanover to pilot LeakBot in the United States
11th Apr 20257:00 amRNSTrading update for the year ended 31 March 2025
2nd Apr 20257:00 amRNSDirector/PDMR Shareholding
1st Apr 20257:00 amRNSTotal Voting Rights
11th Mar 20254:56 pmRNSDirector/PDMR Share Dealing
4th Mar 20257:30 amRNSDirector/PDMR Shareholding
4th Mar 20257:00 amRNS-RMutual of Enumclaw to Expand LeakBot Program
3rd Mar 20257:00 amRNSTotal Voting Rights
17th Feb 20257:00 amRNS-RPURE expands LeakBot program
13th Feb 20257:00 amRNSTrading Update
13th Feb 20257:00 amRNSLiberty Mutual Insurance to Pilot LeakBot in US
5th Feb 202511:54 amRNSWarrant Exercise and Director/PDMR Shareholding
3rd Feb 20252:02 pmRNSDirector/PDMR Shareholding and TVR - Replacement
3rd Feb 20257:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
3rd Feb 20257:00 amRNSBlock listing Interim Review
31st Jan 20257:00 amRNS-RNorthumbrian Water to trial LeakBot
20th Jan 20253:40 pmRNSDirector/PDMR Shareholding
2nd Jan 20257:00 amRNSTotal Voting Rights
23rd Dec 20247:00 amRNSDirector/PDMR Shareholding
20th Dec 20245:58 pmRNSBlock Listing Application - Amendment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.